Skip to content

The Effect of Minoxidil cream on Anal fissure

Randomized double blind controlled clinical trial of Topical 0.5% minoxidil vs. 2% Diltiazem on chronic anal fissure

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015041414483N6
Enrollment
110
Registered
2015-05-12
Start date
2014-12-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Anal fissure. Chronic Anal fissure

Interventions

Intervention 1: Group 1:patients will be apply topical 2% Diltiazem cream twice a day for two weeks. Intervention 2: Group 2: patients will be apply 0.5% Minoxidil cream twice a day for two weeks.
Treatment - Drugs
Group 1:patients will be apply topical 2% Diltiazem cream twice a day for two weeks.
Group 2: patients will be apply 0.5% Minoxidil cream twice a day for two weeks.

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:All the patiens that are of 15 to 65 years old who had suffered from anal fissure and werent recovered after 6 weeks. Exclusion criteria: Hypertensive patients; diabeties; vascular disease and heart failures; malignant patients; the patients with history of chemoterapy; the patients who taking ACEI or Diltiazem as a medication .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Anal Bleeding. Timepoint: Befor intervention- 1,2 mo After intervention. Method of measurement: History.;Wound Healing. Timepoint: Befor intervention- 1,2 mo After intervention. Method of measurement: Mucosal wound coverage.;Anal pain. Timepoint: Befor intervention-1,2mo After intervention. Method of measurement: VAS.

Secondary

MeasureTime frame
Iitching. Timepoint: Befor intervention-1,2mo After intervention. Method of measurement: 5-D pruritis scale.;Headache. Timepoint: Befor intervention-1,2 mo After intervention. Method of measurement: VAS.;Decrease in BP. Timepoint: Befor itervention-1,2 mo After intervention. Method of measurement: mm Hg.;Dizziness. Timepoint: Befor intervention-1,2 mo After intervention. Method of measurement: History.;Allergy. Timepoint: Befor intervention-1,2 mo After intervention. Method of measurement: History.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 25, 2026